GL Ventures
Tiger Global leads $50m round for China's DataCloak
China-based cyber security start-up DataCloak has raised $50 million in an extended Series B round led by Tiger Global Management. Existing investors Matrix Partners China, Jeneration Capital, GL Ventures and GSR Ventures re-upped.
China AR glasses maker Nreal gets $100m Series C
Nreal, a Chinese manufacturer of advanced artificial reality (AR) glasses that resemble normal sunglasses, has raised a Series C of $100 million led by Nio Capital, Yunfeng Capital, and Hongtai Capital.
China's Agile Robots raises $220m
Agile Robots, a Germany and China-based industrial robotics company, has raised a $220 million Series C round led by SoftBank Vision Fund 2.
China vaccine developer Abogen raises $700m
Suzhou Abogen Biosciences, a Chinese vaccine developer targeting COVID-19, has raised $700 million in Series C funding featuring Temasek Holdings, Loyal Valley Capital, and Lilly Asia Ventures.
IDG leads $120m round for China SaaS player Xiaoe Tong
Xiaoe Tong, a Chinese software-as-a-service (SaaS) provider that integrates its products with WeChat, has raised $120 million in Series D funding led by IDG Capital.
China LiDAR specialist Hesai closes $300m Series D
Hesai Technology, a China-based developer of sensors used in autonomous driving, has raised a $300 million Series D round led by GL Ventures.
China chip IP specialist Akrostar raises $78m
Akrostar, a Chinese chip designer established less than a year ago by a team that spun out from US-headquartered industry leader Synopsys, has raised RMB500 million ($78 million) in Series A funding.
China GPs commit $160m to local ADC player
DAC Biotech, a Chinese biotech company specializing in antibody-drug conjugates (ADCs) commonly used as targeted therapies for treating cancer, has raised RMB1 billion ($160 million) in Series C funding led by GL Ventures, CDG Capital, and CPE.
China medical tech supplier AMS raises $100m
China and US-based Access Medical Systems (AMS) has raised a $100 million round co-led by Sequoia Capital China and GL Ventures.
Hong Kong e-commerce tracking start-up secures $66m
AfterShip, a Hong Kong-based e-commerce tracking service provider, has raised a $66 million Series B led by Tiger Global Management. GL Ventures also took part.
China AI drug discovery platform StoneWise raises $100m
StoneWise, a Chinese biotech start-up that uses artificial intelligence (AI) technology to develop new drugs, has raised $100 million in Series B funding across two tranches.
KKR joins $200m round for China coding education start-up
Hetao 101, a Chinese online education platform that provides computer programming courses for children, has raised $200 million in Series C funding led by KKR, Vision Plus Capital, and GL Ventures.
China agricultural drone maker XAG raises $46m
XAG, a Chinese manufacturer of agricultural drones, has raised RMB300 million ($46 million) in funding from GL Ventures.
GL joins $61m Series C for China’s Thousand Oaks
GL Ventures - a VC unit of Hillhouse Capital - and China State-Owned Capital Venture Investment Fund have led a RMB400 million ($61 million) Series C round for Thousand Oaks Biopharmaceuticals, a China-based contract development and manufacturing organization...
China retail SaaS provider Huice secures $100m Series C
Huice, a China-based provider of software for retailers, has raised nearly $100 million in Series C funding led by Singapore’s GIC. GL Ventures, Legend Capital and SoftBank Ventures Asia also participated in the round.
China biotech player Genecast raises $149m Series E
Genecast Biotechnology, a Chinese gene sequencing and precision diagnostics company, has closed a RMB1 billion ($149 million) Series E funding round led by China Structural Reform Fund.
China healthcare SaaS player Taimei raises $176m
Taimei Technology, a Chinese cloud-based software provider that serves the healthcare sector has raised RMB1.2 billion ($176 million) in funding led by Tencent Holdings, GL Ventures and Yunfeng Capital.
China's InventisBio secures $147m Series D
GL Ventures, the China venture capital arm of Hillhouse Capital, has led a $147 million Series D round for Shanghai-based biotech developer InventisBio.
GL Ventures leads $58m Series B in China’s GemPharmatech
GemPharmatech, a Chinese company that provides genetically-modified mice for use in drug tests, has raised RMB400 million ($58.6 million) Series B led by GL Ventures, the VC arm of Hillhouse Capital.
China mixed reality player Nreal secures $40m Series B
Nreal, a Chinese manufacturers of advanced virtual reality glasses that resemble normal sunglasses, has raised $40 million in Series B funding led by local video sharing platform Kuaishou.